ARTHQ — Arch Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Arch Therapeutics, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2019 September 30th	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	2.18	0.959	2.27	0.747	0.223
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2.89	2.14	3.67	2.6	1.95
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.009	0.005	0.005	0.002	0.005
Other Long Term Assets
Total Assets	2.9	2.15	3.68	2.6	1.96
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.714	0.646	1.73	3.32	9.47
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.71	3.65	4.7	6.8	9.47
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-0.807	-1.5	-1.03	-4.19	-7.51
Total Liabilities & Shareholders' Equity	2.9	2.15	3.68	2.6	1.96
Total Common Shares Outstanding